← Leaderboards
Ramiro Ernesto Verdun
University Of Miami School Of Medicine
$3,654,446
Attributed
$5,390,142
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $777.4K · FY2014–25$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,390,142 · 4
By mechanism
R01$5,006,392 · 3
R56$383,750 · 1
Top collaborators
- Izidore S Lossos5 shared
- Lluis Morey4 shared
Most similar at University Of Miami School Of Medicine
Same institution · by research overlap
- Izidore S Lossos$4,248,673
- Daniel Pelaez$1,186,565
- Lluis Morey$2,852,313
- Eddy Yang$1,454,659
- Daniel Alexander Rodriguez$142,960
Others in their field
Top investigators on “Dna Repair”
- John A Tainer · Scripps Research Institute$45,990,082
- Aziz Sancar · University Of North Carolina Chapel Hill$30,640,499
- Patrick Sung · University Of Texas Hlth Sci Ctr San Ant$30,442,761
- John M Essigmann · Massachusetts Institute Of Technology$27,654,594
- Loic Le Marchand · University Of Hawaii At Manoa$26,643,180
- Maria Jasin · Sloan-Kettering Institute For Cancer Res$25,953,946
Research focus
Dna RepairMediatingGenomic InstabilityS LymphomaMolecularPathway InteractionsDna Double Strand BreakPlayLeadB-LymphocytesIn VitroNovel Therapeutic InterventionImmunoglobulin Switch RecombinationChromosomal TranslocationImmune ResponseComplexAffectImmunoglobulin Class SwitchingHomologous RecombinationCell DeathGenome StabilityFunctional DisorderDouble Strand Break RepairGenome
Grant awards (15)
Altering the chromostasis and genome stability by modulating histone methylation$418,755
R01 · FY2025 · GM
Altering the chromostasis and genome stability by modulating histone methylation$419,504
R01 · FY2024 · GM
Altering the chromostasis and genome stability by modulating histone methylation$425,068
R01 · FY2023 · GM
Identify the Mechanisms of LMO2-Mediated Inhibition of Homologous Recombination and Establish PARP-Targeted Synthetic Lethality as a New Therapy for DLBCL$352,286
R01 · FY2023 · CA
Altering the chromostasis and genome stability by modulating histone methylation$425,068
R01 · FY2022 · GM
Identify the Mechanisms of LMO2-Mediated Inhibition of Homologous Recombination and Establish PARP-Targeted Synthetic Lethality as a New Therapy for DLBCL$352,283
R01 · FY2022 · CA
Identify the Mechanisms of LMO2-Mediated Inhibition of Homologous Recombination and Establish PARP-Targeted Synthetic Lethality as a New Therapy for DLBCL$359,476
R01 · FY2021 · CA
Role of TRF2 in DNA recombination$307,000
R01 · FY2021 · GM · contact PI
Identify the Mechanisms of LMO2-Mediated Inhibition of Homologous Recombination and Establish PARP-Targeted Synthetic Lethality as a New Therapy for DLBCL$359,476
R01 · FY2020 · CA
Role of TRF2 in DNA recombination$307,000
R01 · FY2020 · GM · contact PI
Identify the Mechanisms of LMO2-Mediated Inhibition of Homologous Recombination and Establish PARP-Targeted Synthetic Lethality as a New Therapy for DLBCL$359,476
R01 · FY2019 · CA
Role of TRF2 in DNA recombination$307,000
R01 · FY2019 · GM · contact PI
Role of TRF2 in DNA recombination$307,000
R01 · FY2018 · GM · contact PI
Role of TRF2 in DNA recombination$307,000
R01 · FY2017 · GM · contact PI
Role of Telomeric Proteins in Antibody Class Switch Recombination$383,750
R56 · FY2014 · AI · contact PI